84 related articles for article (PubMed ID: 25261662)
41. Health related quality of life in locally advanced NSCLC treated with high dose radiotherapy and concurrent chemotherapy or cetuximab--pooled results from two prospective clinical trials.
Hallqvist A; Bergman B; Nyman J
Radiother Oncol; 2012 Jul; 104(1):39-44. PubMed ID: 22727262
[TBL] [Abstract][Full Text] [Related]
42. Association of ERCC1-C118T and -C8092A polymorphisms with lung cancer risk and survival of advanced-stage non-small cell lung cancer patients receiving platinum-based chemotherapy: a pooled analysis based on 39 reports.
Xu TP; Shen H; Liu LX; Shu YQ
Gene; 2013 Sep; 526(2):265-74. PubMed ID: 23727606
[TBL] [Abstract][Full Text] [Related]
43. Pathologic response rates following definitive dose image-guided chemoradiotherapy and resection for locally advanced non-small cell lung cancer.
Shumway D; Corbin K; Salgia R; Hoffman P; Villaflor V; Malik RM; Haraf DJ; Vigneswaren WT; Shaikh AY; Connell PP; Ferguson MK; Salama JK
Lung Cancer; 2011 Dec; 74(3):446-50. PubMed ID: 21676484
[TBL] [Abstract][Full Text] [Related]
44. Long-term results in patients with pathological complete response after induction radiochemotherapy followed by surgery for locally advanced non-small-cell lung cancer.
Lococo F; Cesario A; Margaritora S; Dall'Armi V; Mattei F; Romano R; Porziella V; Granone P
Eur J Cardiothorac Surg; 2013 Mar; 43(3):e71-81. PubMed ID: 23293319
[TBL] [Abstract][Full Text] [Related]
45. Expression of Bcl-2 predicts outcome in locally advanced non-small cell lung cancer patients treated with cisplatin-based concurrent chemoradiotherapy.
Jeong SH; Jung JH; Han JH; Kim JH; Choi YW; Lee HW; Kang SY; Hwang YH; Ahn MS; Choi JH; Oh YT; Chun M; Kang S; Park KJ; Hwang SC; Sheen SS
Lung Cancer; 2010 May; 68(2):288-94. PubMed ID: 19560836
[TBL] [Abstract][Full Text] [Related]
46. A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group.
Segawa Y; Ueoka H; Kiura K; Kamei H; Tabata M; Sakae K; Hiraki Y; Kawahara S; Eguchi K; Hiraki S; Harada M
Br J Cancer; 2000 Jan; 82(1):104-11. PubMed ID: 10638975
[TBL] [Abstract][Full Text] [Related]
47. Erlotinib in the treatment of advanced squamous cell NSCLC.
Fiala O; Pesek M; Finek J; Krejci J; Havel L; Hrnciarik M; Salajka F; Bortlicek Z; Benesova L; Minarik M
Neoplasma; 2013; 60(6):676-82. PubMed ID: 23906302
[TBL] [Abstract][Full Text] [Related]
48. A population-based study of primary chemoradiotherapy in clinical stage III non-small cell lung cancer: intensity-modulated radiotherapy versus 3D conformal radiotherapy.
Hsia TC; Tu CY; Chen HJ; Chen SC; Liang JA; Chen CY; Wang YC; Chien CR
Anticancer Res; 2014 Sep; 34(9):5175-80. PubMed ID: 25202111
[TBL] [Abstract][Full Text] [Related]
49. Wait times in diagnostic evaluation and treatment for patients with stage III non-small cell lung cancer in British Columbia.
Wai ES; Mackinnon M; Hooker R; Moccia P; Perry KR; Truong PT
Am J Clin Oncol; 2012 Aug; 35(4):373-7. PubMed ID: 21422900
[TBL] [Abstract][Full Text] [Related]
50. Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial.
Butts C; Socinski MA; Mitchell PL; Thatcher N; Havel L; Krzakowski M; Nawrocki S; Ciuleanu TE; Bosquée L; Trigo JM; Spira A; Tremblay L; Nyman J; Ramlau R; Wickart-Johansson G; Ellis P; Gladkov O; Pereira JR; Eberhardt WE; Helwig C; Schröder A; Shepherd FA;
Lancet Oncol; 2014 Jan; 15(1):59-68. PubMed ID: 24331154
[TBL] [Abstract][Full Text] [Related]
51. Excessive splenic volume is an unfavorable prognostic factor in patients with non-small cell lung cancer treated with chemoradiotherapy.
Guo J; Wang L; Wang X; Li L; Lü Y; Wang C; Hao C; Zhang J
Medicine (Baltimore); 2020 Dec; 99(49):e23321. PubMed ID: 33285708
[TBL] [Abstract][Full Text] [Related]
52. Progression-free survival at 2 years is a reliable surrogate marker for the 5-year survival rate in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy.
Akamatsu H; Mori K; Naito T; Imai H; Ono A; Shukuya T; Taira T; Kenmotsu H; Murakami H; Endo M; Harada H; Takahashi T; Yamamoto N
BMC Cancer; 2014 Jan; 14():18. PubMed ID: 24422706
[TBL] [Abstract][Full Text] [Related]
53. Pretreatment financial toxicity predicts progression-free survival following concurrent chemoradiotherapy for locally advanced non-small-cell lung cancer.
Klein J; Bodner W; Garg M; Kalnicki S; Ohri N
Future Oncol; 2019 May; 15(15):1697-1705. PubMed ID: 30977688
[No Abstract] [Full Text] [Related]
54. Evaluation of the relationship of erythrocyte membrane Na+/K+-ATPase enzyme activity and tumor response to chemoradiotherapy in patients diagnosed with locally advanced nonsmall cell lung cancer and glioblastoma multiforme.
Cetinkaya CD; Gurbilek M; Koc M
J Cancer Res Ther; 2018 Jun; 14(Supplement):S450-S456. PubMed ID: 29970705
[TBL] [Abstract][Full Text] [Related]
55. Relationship between Trace Element in Tumor and Prognosis in Lung Cancer Patients.
Saikawa H; Nagashima H; Cho K; Chiba R; Sera K; Shigeeda W; Tomoyasu M; Deguchi H; Takahashi F; Saito H; Sugai T; Maemondo M
Medicina (Kaunas); 2021 Feb; 57(3):. PubMed ID: 33652756
[No Abstract] [Full Text] [Related]
56. Evaluation of the relationship between serum ghrelin levels and cancer cachexia in patients with locally advanced nonsmall-cell lung cancer treated with chemoradiotherapy.
Uysal P; Afsar CU; Sozer V; Inanc B; Agaoglu F; Gural Z; Fazlıoglu NY; Cuhadaroglu C; Uzun H
J Cancer Res Ther; 2020; 16(4):855-859. PubMed ID: 32930130
[TBL] [Abstract][Full Text] [Related]
57. A case-control study of trace-element status and lung cancer in Appalachian Kentucky.
Unrine JM; Slone SA; Sanderson W; Johnson N; Durbin EB; Shrestha S; Hahn EJ; Feltner F; Huang B; Christian WJ; Mellon I; Orren DK; Arnold SM
PLoS One; 2019; 14(2):e0212340. PubMed ID: 30811496
[TBL] [Abstract][Full Text] [Related]
58. Hair trace element analysis in human ecology studies.
Batzevich VA
Sci Total Environ; 1995 Mar; 164(2):89-98. PubMed ID: 7725082
[TBL] [Abstract][Full Text] [Related]
59. Therapeutic efficacy of rare earth carbonate with chemoradiotherapy in late-stage non-small cell lung cancer: a cohort prospective study.
Cao Q; Ye X; Wu X; Zhang Q; Gong J; Chen Y; You Y; Shen J; Qiang Y; Cao G
Front Endocrinol (Lausanne); 2023; 14():1301032. PubMed ID: 38192415
[TBL] [Abstract][Full Text] [Related]
60. The impact of lifestyle factors on age-related differences in hair trace element content in pregnant women in the third trimester.
Skalny AV; Tinkov AA; Voronina I; Terekhina O; Skalnaya MG; Bohan TG; Agarkova LA; Kovas Y
Acta Sci Pol Technol Aliment; 2018; 17(1):83-89. PubMed ID: 29514427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
